Glioblastoma is heterogeneous in the molecular subtypes based on transcriptomic classification. In this issue of Cancer Cell, Wang et al. define a cell-lineage-based stratification model for glioblastoma, highlighting how the cell of origin generates distinct molecular landscapes and therapeutic vulnerabilities from identical driver mutations.
|Original language||English (US)|
|Number of pages||3|
|State||Published - Sep 14 2020|
ASJC Scopus subject areas
- Cancer Research